BWXT Technologies announced a definitive agreement to acquire Precision Components Group, LLC, along with its subsidiaries Precision Custom Components and DC Fabricators, adding more than 500,000 square feet of manufacturing space and over 400 employees in York, Pennsylvania and Florence, New Jersey.
The deal expands BWXT’s heavy‑manufacturing footprint and adds U.S. commercial nuclear production capacity, positioning the company as the sole‑source provider of naval nuclear components and the only North American manufacturer of commercial heavy nuclear components.
PCG generated approximately $125 million in revenue in 2025 and has capabilities in large‑envelope machining, heavy weldments, pressure vessels, heat exchangers, and ASME‑certified component fabrication. The acquisition will integrate PCG’s expertise in complex, heavy‑walled and heat‑transfer components, strengthening BWXT’s ability to meet growing demand for small‑modular‑reactor (SMR) components, medical isotopes, and other high‑value nuclear products.
BWXT’s recent performance has been driven by strong growth in both its Government Operations and Commercial Operations segments. The company reported record 2025 revenue of $3.2 billion, up 18 percent year‑over‑year, and a backlog of more than $7.3 billion, fueled by multi‑year awards in naval propulsion, special materials, and commercial nuclear projects.
Management highlighted that the acquisition creates an immediate commercial manufacturing footprint that complements BWXT’s existing service offerings to U.S. customers and leverages its commercial engineering expertise and supplier base. The transaction is expected to close in the second half of 2026 and is subject to regulatory approvals.
The deal aligns with BWXT’s broader strategy to scale capacity and secure additional domestic production capabilities in a market with limited supply and high pricing power, reinforcing the company’s position amid growing demand for clean energy, SMR development, and medical isotope production.
The content on EveryTicker is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.